BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12205549)

  • 1. Intravenous calcium injection test is a novel complementary procedure in differential diagnosis for gastrinoma.
    Wada M; Komoto I; Doi R; Imamura M
    World J Surg; 2002 Oct; 26(10):1291-6. PubMed ID: 12205549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.
    Chatzipanagiotou O; Schizas D; Vailas M; Tsoli M; Sakarellos P; Sotiropoulou M; Papalambros A; Felekouras E
    J Neuroendocrinol; 2023 Apr; 35(4):e13267. PubMed ID: 37042078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of selective arterial secretin injection test in treatment of gastrinoma.
    Shibata C; Funayama Y; Fukushima K; Takahashi K; Ueno T; Nagao M; Haneda S; Watanabe K; Kudoh K; Kohyama A; Naito H; Sasaki I
    Hepatogastroenterology; 2006; 53(72):960-3. PubMed ID: 17153463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic and therapeutic strategies in Zollinger-Ellison syndrome associated with multiple endocrine neoplasia type I (MEN-I): experience of the Zollinger-Ellison Syndrome Research Group: Bichat 1958-1999].
    Mignon M
    Bull Acad Natl Med; 2003; 187(7):1249-58; discussion 1259-60. PubMed ID: 15146602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias.
    Tonelli F; Fratini G; Nesi G; Tommasi MS; Batignani G; Falchetti A; Brandi ML
    Ann Surg; 2006 Jul; 244(1):61-70. PubMed ID: 16794390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of selective arterial secretin injection test to guide surgery in patients with Zollinger-Ellison syndrome.
    Imamura M; Takahashi K
    World J Surg; 1993; 17(4):433-8. PubMed ID: 8362526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet cell tumors and the ulcerogenic syndrome.
    McGuigan JE
    Monogr Pathol; 1980; 21():177-84. PubMed ID: 6261121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
    Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
    Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zollinger-Ellison syndrome: pathogenesis, diagnosis, and management.
    Hirschowitz BI
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):44S-48S; discussion 49S-50S. PubMed ID: 9127626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.
    Berna MJ; Hoffmann KM; Long SH; Serrano J; Gibril F; Jensen RT
    Medicine (Baltimore); 2006 Nov; 85(6):331-364. PubMed ID: 17108779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of a selective surgical approach to management of Zollinger-Ellison syndrome in patients with MEN-1.
    Mortellaro VE; Hochwald SN; McGuigan JE; Copeland EM; Vogel SB; Grobmyer SR
    Am Surg; 2009 Aug; 75(8):730-3. PubMed ID: 19725300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of gastrinoma by the secretin suppression test.
    Bradley EL; Galambos JT
    Surg Gynecol Obstet; 1976 Nov; 143(5):784-8. PubMed ID: 982259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretin provocation test in the diagnosis of Zollinger-Ellison syndrome.
    Brady CE
    Am J Gastroenterol; 1991 Feb; 86(2):129-34. PubMed ID: 1992623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Which diagnostic and therapeutic approach to the Zollinger-Ellison syndrome should be adopted in 1990?].
    Mignon M; Benhamou G
    Acta Chir Belg; 1991; 91(2):88-95. PubMed ID: 1676864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False-positive secretin stimulation test for gastrinoma associated with the use of proton pump inhibitor therapy.
    Goldman JA; Blanton WP; Hay DW; Wolfe MM
    Clin Gastroenterol Hepatol; 2009 May; 7(5):600-2. PubMed ID: 19245850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of calcium provocative test in the diagnosis of gastroenteropancreatic endocrine tumors.
    Vezzadini C; Poggioli R; Casoni I; Vezzadini P
    Panminerva Med; 1996 Dec; 38(4):255-8. PubMed ID: 9063035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretin Stimulation Test and Early Diagnosis of Gastrinoma in MEN1 Syndrome: Survey on the MEN1 Florentine Database.
    Giusti F; Cioppi F; Fossi C; Marini F; Masi L; Tonelli F; Brandi ML
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2110-e2123. PubMed ID: 34922358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gastrinoma: diagnosis and management of Zollinger-Ellison syndrome].
    Sugihara K
    Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1044-8. PubMed ID: 6150432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing treatment strategy for gastrinoma in patients with Zollinger-Ellison syndrome.
    Imamura M; Komoto I; Ota S
    World J Surg; 2006 Jan; 30(1):1-11. PubMed ID: 16369713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of patients with Zollinger-Ellison syndrome.
    Meko JB; Norton JA
    Annu Rev Med; 1995; 46():395-411. PubMed ID: 7598474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.